The Epidermal Growth Factor Receptor Inhibitor Market is influenced by the growing use of personalized treatment planning. Oncologists consider tumor biomarkers, patient health, potential adverse effects, and previous therapies when determining the most appropriate treatment strategy.
The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 billion by 2034 from...
